NanoLogix, Inc. Makes Stock Pick List
HUBBARD, Ohio, Jan 08, 2008 /PRNewswire-FirstCall via COMTEX/ -- NanoLogix, Inc.
(OTC: NNLX), a nano-biotechnology company is pleased to announce that the company has
been named "Stock Pick of January 2008" by Stockprowler (http://www.stockprowler.com).
Dana Allen, NanoLogix vice president, stated that "This is another example of our
company getting increased attention from the investment community. We are happy to
be selected by Stockprowler -- an independent stock scouting service who came to
their decision through public research and one that receives no compensation from
the companies they profile."
About NanoLogix, Inc.
Read the
Stockprowler.com article here.
NanoLogix is a leading innovator in the research, development,
and commercialization of nano-biotechnologies, applications and
processes. The Company has 31 granted Patents and 36 Patents
Pending for bioreactor-based Hydrogen Production, revolutionary
rapid medical testing technologies, potential treatments for sepsis
and cancer (via apoptosis), and bioremediation. Information on
NanoLogix is available at http://www.nanologixinc.com.
________________________________________
Contact:
NanoLogix, Inc.
Investor Relations
Bret Barnhizer, CEO
Telephone: 330-534-0800
E-mail:
Bret@nanologixinc.com
